Trademark: 79048077
Word
SPECIALITY EUROPEAN PHARMA
Status
Dead
Status Code
404
Status Date
Thursday, December 7, 2017
Serial Number
79048077
Registration Number
3537335
Registration Date
Tuesday, November 25, 2008
Mark Type
3000
Filing Date
Friday, December 7, 2007
Published for Opposition
Tuesday, September 9, 2008
Cancellation Date
Thursday, December 7, 2017

Trademark Owner History
Speciality European Pharma Limited - Original Registrant

Classifications
5 Pharmaceutical preparations for use in oncology, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, neurological, dermatological, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory disorders, immune system disorders including autoimmune diseases, metabolic disorders, psychiatric disorders, allergic reactions, infectious diseases, occular disorders, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntingdon's disease, spinal muscular atrophy, adenomatous polyposis coli, reproductive disorders, endocrinology disease, urological disorders, respiratory disorders, asthma, allergies, cancers, infectious organisms, bacterial infections, drug resistance, bacterial drug resistance, metabolic disorders, inflammation, cardiovascular diseases, viral infections, gene therapy treatments, viral latency, genetic disorders, sickle cell anaemia, restenosis, thallasemia, bacterial infections, diabetes, central nervous system disorders and diseases, depression, schizophrenia, obesity, parasitic infections, fungal infections, skin diseases, arthritis, osteoporosis, circulatory diseases, degenerative disorders, autoimmune disease, gastrointestinal disorders and diseases, musculoskeletal disorders and diseases, renal disease, connective tissue and joint disease, eye disease
Color is not claimed as a feature of the mark.
"EUROPEAN PHARMA"
SPECIALITY EUROPEAN PHARMACEUTICAL

Trademark Events
Jun 29, 2018
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jun 29, 2018
Death Of International Registration
Mar 31, 2017
Total Invalidation Processed By The Ib
Apr 22, 2016
Total Invalidation Of Reg Ext Protection Sent To Ib
Apr 22, 2016
Invalidation Processed
Feb 26, 2016
Total Invalidation Of Reg Ext Protection Created
Sep 10, 2015
New Representative At Ib Received
Jun 26, 2015
Cancelled Section 71
Jan 7, 2013
Final Decision Transaction Processed By Ib
Nov 30, 2011
Teas Change Of Correspondence Received
Mar 18, 2009
Final Disposition Notice Sent To Ib
Mar 18, 2009
Final Disposition Processed
Feb 26, 2009
Final Disposition Notice Created, To Be Sent To Ib
Nov 25, 2008
Registered-Principal Register
Sep 9, 2008
Published For Opposition
Aug 20, 2008
Notice Of Publication
Aug 5, 2008
Law Office Publication Review Completed
Aug 4, 2008
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 4, 2008
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 5, 2008
Assigned To Lie
Jul 31, 2008
Approved For Pub - Principal Register
Jun 6, 2008
Teas Change Of Correspondence Received
Jun 6, 2008
Teas/Email Correspondence Entered
Jun 6, 2008
Correspondence Received In Law Office
Jun 6, 2008
Teas Response To Office Action Received
Apr 19, 2008
Refusal Processed By Ib
Mar 26, 2008
Non-Final Action Mailed - Refusal Sent To Ib
Mar 26, 2008
Refusal Processed By Mpu
Mar 26, 2008
Non-Final Action (Ib Refusal) Prepared For Review
Mar 25, 2008
Non-Final Action Written
Mar 18, 2008
Assigned To Examiner
Feb 1, 2008
New Application Entered In Tram
Jan 31, 2008
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24